UY27628A1 - "2'-halo -3',5'-dialcoxi-fen-1'il-2-imidazolidinas y su uso como un fármaco" - Google Patents

"2'-halo -3',5'-dialcoxi-fen-1'il-2-imidazolidinas y su uso como un fármaco"

Info

Publication number
UY27628A1
UY27628A1 UY27628A UY27628A UY27628A1 UY 27628 A1 UY27628 A1 UY 27628A1 UY 27628 A UY27628 A UY 27628A UY 27628 A UY27628 A UY 27628A UY 27628 A1 UY27628 A1 UY 27628A1
Authority
UY
Uruguay
Prior art keywords
halo
fen
imidazolidins
dialcoxi
drug
Prior art date
Application number
UY27628A
Other languages
English (en)
Inventor
Prof Ikunobu Muramatau
Dr Franz Esser
Mrs Dr Pascale Pouzet
Naoki Ishiguro
Dr Hisato Kiragawa
Original Assignee
Boehringer Ingelheim Pharma
Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma, Co Kg filed Critical Boehringer Ingelheim Pharma
Publication of UY27628A1 publication Critical patent/UY27628A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

El presente invento se refiere a 2'-halo-3',5`-dialcoxi-fen-1'il-imino-2-imidazolidinas, las 2'-halo-3',5'-dialcoxi-anilino-2-imidazolinas tautómera y/o las sales farmacológicamente aceptable de las mismas y su uso como composiciones farmacéuticas.
UY27628A 2002-01-31 2003-01-29 "2'-halo -3',5'-dialcoxi-fen-1'il-2-imidazolidinas y su uso como un fármaco" UY27628A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02002352A EP1333028A1 (en) 2002-01-31 2002-01-31 2'-Halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine derivatives and the use thereof for the treatment of urinary incontinence

Publications (1)

Publication Number Publication Date
UY27628A1 true UY27628A1 (es) 2003-08-29

Family

ID=8185397

Family Applications (1)

Application Number Title Priority Date Filing Date
UY27628A UY27628A1 (es) 2002-01-31 2003-01-29 "2'-halo -3',5'-dialcoxi-fen-1'il-2-imidazolidinas y su uso como un fármaco"

Country Status (20)

Country Link
EP (2) EP1333028A1 (es)
JP (1) JP2005516066A (es)
KR (1) KR20040074134A (es)
CN (1) CN1617857A (es)
AR (1) AR038380A1 (es)
BR (1) BR0215560A (es)
CA (1) CA2474588A1 (es)
EA (1) EA200400877A1 (es)
EC (1) ECSP045210A (es)
HR (1) HRP20040691A2 (es)
HU (1) HUP0402654A2 (es)
IL (1) IL162776A0 (es)
MX (1) MXPA04007250A (es)
NO (1) NO20043614L (es)
PE (1) PE20030819A1 (es)
PL (1) PL369826A1 (es)
TW (1) TW200418462A (es)
UY (1) UY27628A1 (es)
WO (1) WO2003064398A1 (es)
ZA (1) ZA200405173B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4168086B1 (ja) * 2008-04-16 2008-10-22 国立大学法人福井大学 イミダゾリン誘導体
BRPI0913019A2 (pt) 2008-05-13 2015-10-13 Allergan Inc naftilmetilimidazóis para o tratamento de incontinência urinária por estresse
CA2724293A1 (en) * 2008-05-13 2009-11-19 Allergan, Inc. Quinolynylmethylimidizoles as therapeutic agents
US9034910B2 (en) 2008-06-09 2015-05-19 Allergan, Inc. Methods of treating alpha adrenergic mediated conditions
WO2009152053A1 (en) * 2008-06-09 2009-12-17 Allergan, Inc. Methods of treating alpha adrenergic mediated conditions using imidazoline derivates
CN102099032B (zh) * 2008-06-09 2014-07-09 阿勒根公司 治疗α肾上腺素能介导的病症的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2220906A1 (de) * 1972-04-28 1973-11-15 Boehringer Sohn Ingelheim Neue substituierte 2-phenylaminoimidazoline-(2), deren saeureadditionssalze sowie verfahren zu deren herstellung
DE2259160A1 (de) * 1972-12-02 1974-06-06 Boehringer Sohn Ingelheim Neue substituierte 2-phenylaminoimidazoline, deren saeureadditionssalze und verfahren zur herstellung derselben sowie ihre verwendung als arzneimittel
AT333749B (de) * 1974-07-03 1976-12-10 Chemie Linz Ag Verfahren zur herstellung von neuen 2-arylamino-2-imidazolinderivaten
MTP837B (en) * 1977-11-07 1979-10-22 Hoffman La Roche And Co Aktien Derivatives 2 finino-imidazolidire
DE3514351A1 (de) * 1985-04-20 1986-11-06 Boehringer Ingelheim KG, 6507 Ingelheim Neue substituierte 2-(n-alkinyl-n-phenyl)amino)-imidazolinderivate, deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zu deren herstellung
DE19514579A1 (de) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz
SG72827A1 (en) * 1997-06-23 2000-05-23 Hoffmann La Roche Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives
DE19740176C2 (de) * 1997-09-12 2000-04-06 Lemfoerder Metallwaren Ag Handschaltvorrichtung für ein Kraftfahrzeug

Also Published As

Publication number Publication date
EP1472231A1 (en) 2004-11-03
EP1333028A1 (en) 2003-08-06
MXPA04007250A (es) 2004-10-29
NO20043614L (no) 2004-08-30
CA2474588A1 (en) 2003-08-07
PE20030819A1 (es) 2003-10-20
BR0215560A (pt) 2004-12-21
JP2005516066A (ja) 2005-06-02
HRP20040691A2 (en) 2004-12-31
AR038380A1 (es) 2005-01-12
EA200400877A1 (ru) 2005-02-24
ZA200405173B (en) 2005-06-21
PL369826A1 (en) 2005-05-02
CN1617857A (zh) 2005-05-18
HUP0402654A2 (hu) 2005-03-29
WO2003064398A1 (en) 2003-08-07
IL162776A0 (en) 2005-11-20
ECSP045210A (es) 2004-09-28
KR20040074134A (ko) 2004-08-21
TW200418462A (en) 2004-10-01

Similar Documents

Publication Publication Date Title
CY1119261T1 (el) Παραγωγα θειαζολιου
RS51569B (en) COMPOSITIONS CONTAINING CRYSTAL TRANS - (+/-) - DELTA-9-TETRAHYDROCANABINOL
EA200801083A1 (ru) Новые производные дигидропсевдоэритромицина
ATE493386T1 (de) Trans-3-aza-bicyclo-ä3.1.0ü-hexan-derivate
CY1113003T1 (el) Ευσταθη παρασκευασματα laquinimod
EA200901393A1 (ru) Фармацевтическая композиция, содержащая гестагены и/или эстрогены и 5 метил-(6s)-тетрагидрофолат
PL410219A1 (pl) Kompozycja zawierająca koniugat leku obejmujący pochodne kalicheamycyny i przeciwciało, oraz kompozycja farmaceutyczna ją zawierająca
MEP39108A (en) Pharmaceutical composition
CY1111705T1 (el) Παραγωγα 2-αζα-δικυκλο[3.1.0]εξανιου ως ανταγωνιστες του υποδοχεα ορεξινης
CY1106996T1 (el) Δισκιο με υψηλο φορτιο φαρμακου
UY27455A1 (es) Derivados n-(1,4,5,6-tetrahidro-ciclopentapirazol -3-il)- sustituidos. su obtención y uso como fármacos.
BR0313385A (pt) Derivados de pirimidina-2,4-diona como inibidores de metaloproteinase da matriz
BRPI0311189B8 (pt) composições farmacêuticas contendo polimorfo a de flibanserin, bem como seu uso
NO20064808L (no) Orale matrixformuleringer med licarbazepin
BR0209440A (pt) Sulfonamidas
DOP2006000024A (es) Tiazolidinonas, su preparación y su uso como medicamento
UY27018A1 (es) Derivados de la pirimidina
BRPI0509014A (pt) comprimidos desintegráveis que compreendem licarbazepina
BRPI0417950A (pt) composições farmacêuticas
ITMI20021725A1 (it) Composizioni farmaceutiche ad attivita' antibiotica.
ITRM20030355A1 (it) Composti ad attivita' citotossica derivati della combretastatina.
UY27628A1 (es) "2'-halo -3',5'-dialcoxi-fen-1'il-2-imidazolidinas y su uso como un fármaco"
ATE465741T1 (de) 9a-carbamoyl-y-aminopropyl- und 9a-thiocarbamoyl- y-aminopropyl-azalide mit antimalaria-aktivität
ATE460934T1 (de) Pharmazeutische zubereitungen von ciprofloxacin
BRPI0417205A (pt) composições farmacêuticas

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20150212